RBM38 and acute myeloid leukemia: These results are supported by the results from a recent study by Wampfler et al.   62  where the expression of the RNA binding proteins RBM38 and DND1 were repressed in primary AML patients, and neutrophil differentiation was dependent on increased expression of both proteins.